Latest Breaking News On - Rare disease business unit - Page 3 : comparemela.com

BioNJ elects officers, board for 2022

BioNJ announced its 2022 board officers and trustees; elections took place before the organization's Annual Board meeting on Feb. 2.

Short hillsNew jerseyUnited statesRutgers universityNew brunswickChristopher schaberKathleen covielloStuart peltzAzurrx biopharmaJayne gershkowitzBob smithDebbie hartSpiro rombotisSol barerChristian kopfliEmer leahy

X4 Pharmaceuticals Expands Commercial Leadership Expertise

Each brings significant experience in strategic marketing of rare disease therapeutics and commercial operations.

United statesRegion flamandePaula raganAvexis europeRouco molinaYale universityMichael allen companyRaptor pharmaceuticals europeExchange commissionTakeda pharmaceuticalsLifesci communicationsMarketing at vertex pharmaceuticalsPharmaceuticals incUniversity of leuvenKarolyn parkVice president

X4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U S Commercial

X4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U S Commercial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRegion flamandeDaniel ferrymanagingPaula raganAvexis europeYale universityMichael allen companyRaptor pharmaceuticals europeExchange commissionTakeda pharmaceuticalsMarketing at vertex pharmaceuticalsPharmaceuticals incUniversity of leuvenKarolyn parkVice presidentChief executive officer